Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
RECOVERY Collaborative Group None. et al, (2022)
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), The Lancet. Respiratory medicine, 9, 1419 - 1426
The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.
Journal article
Spartera M. et al, (2021), Eur Heart J Cardiovasc Imaging
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.
Journal article
Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113
Making trials part of good clinical care: lessons from the RECOVERY trial.
Journal article
Pessoa-Amorim G. et al, (2021), Future Healthc J, 8, e243 - e250
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645
Left atrial 4D flow cardiovascular magnetic resonance: a reproducibility study in sinus rhythm and atrial fibrillation.
Journal article
Spartera M. et al, (2021), J Cardiovasc Magn Reson, 23
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
The RECOVERY Collaborative Group None. et al, (2021)
Left ventricular reverse remodeling and function by strain analysis in aortic stenosis: A CMR analysis of the EPICHEART study.
Journal article
Azevedo D. et al, (2021), Rev Port Cardiol (Engl Ed), 40, 153 - 164
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Working paper
RECOVERY Collaborative Group None. et al, (2021)
Influence of EPICardial adipose tissue in HEART diseases (EPICHEART) study: Protocol for a translational study in coronary atherosclerosis.
Journal article
Mancio J. et al, (2020), Rev Port Cardiol (Engl Ed), 39, 625 - 633
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology.
Journal article
Pessoa-Amorim G. et al, (2020), Eur Heart J Qual Care Clin Outcomes, 6, 210 - 216
Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study.
Journal article
Mancio J. et al, (2020), Atherosclerosis, 292, 75 - 83
Impaired Left Atrial Strain as a Predictor of New-onset Atrial Fibrillation After Aortic Valve Replacement Independently of Left Atrial Size.
Journal article
Pessoa-Amorim G. et al, (2018), Rev Esp Cardiol (Engl Ed), 71, 466 - 476